230 related articles for article (PubMed ID: 11423453)
21. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
[TBL] [Abstract][Full Text] [Related]
22. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.
Verhoef P; Stampfer MJ; Buring JE; Gaziano JM; Allen RH; Stabler SP; Reynolds RD; Kok FJ; Hennekens CH; Willett WC
Am J Epidemiol; 1996 May; 143(9):845-59. PubMed ID: 8610698
[TBL] [Abstract][Full Text] [Related]
23. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
24. Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations.
Malinow MR; Duell PB; Williams MA; Kruger WD; Evans AA; Anderson PH; Block PC; Hess DL; Upson BM; Graf EE; Irvin-Jones A; Wang L
Lipids; 2001; 36 Suppl():S27-32. PubMed ID: 11837988
[TBL] [Abstract][Full Text] [Related]
25. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.
Eikelboom JW; Hankey GJ; Anand SS; Lofthouse E; Staples N; Baker RI
Stroke; 2000 May; 31(5):1069-75. PubMed ID: 10797167
[TBL] [Abstract][Full Text] [Related]
26. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay.
Herrmann W; Obeid R; Schorr H; Zarzour W; Geisel J
Clin Chem Lab Med; 2003 Apr; 41(4):547-53. PubMed ID: 12747601
[TBL] [Abstract][Full Text] [Related]
27. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects.
Lalouschek W; Aull S; Serles W; Schnider P; Mannhalter C; Lang T; Deecke L; Zeiler K
J Lab Clin Med; 1999 Jun; 133(6):575-82. PubMed ID: 10360632
[TBL] [Abstract][Full Text] [Related]
28. Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden.
Thögersen AM; Nilsson TK; Dahlen G; Jansson JH; Boman K; Huhtasaari F; Hallmans G
Coron Artery Dis; 2001 Mar; 12(2):85-90. PubMed ID: 11281306
[TBL] [Abstract][Full Text] [Related]
29. Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion.
Larsson J; Hultberg B; Hillarp A
Acta Ophthalmol Scand; 2000 Jun; 78(3):340-3. PubMed ID: 10893069
[TBL] [Abstract][Full Text] [Related]
30. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
[TBL] [Abstract][Full Text] [Related]
31. Hyperhomocysteinemia, low folate status, homozygous C677T mutation of the methylene tetrahydrofolate reductase and renal arterial thrombosis.
Queffeulou G; Michel C; Vrtovsnik F; Philit JB; Dupuis E; Mignon F
Clin Nephrol; 2002 Feb; 57(2):158-62. PubMed ID: 11863127
[TBL] [Abstract][Full Text] [Related]
32. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese.
Morita H; Kurihara H; Tsubaki S; Sugiyama T; Hamada C; Kurihara Y; Shindo T; Oh-hashi Y; Kitamura K; Yazaki Y
Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1465-9. PubMed ID: 9743236
[TBL] [Abstract][Full Text] [Related]
33. Low vitamin B6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification.
Kelly PJ; Shih VE; Kistler JP; Barron M; Lee H; Mandell R; Furie KL
Stroke; 2003 Jun; 34(6):e51-4. PubMed ID: 12738890
[TBL] [Abstract][Full Text] [Related]
34. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506).
Cattaneo M; Tsai MY; Bucciarelli P; Taioli E; Zighetti ML; Bignell M; Mannucci PM
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1662-6. PubMed ID: 9327760
[TBL] [Abstract][Full Text] [Related]
35. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects.
Gemmati D; Previati M; Serino ML; Moratelli S; Guerra S; Capitani S; Forini E; Ballerini G; Scapoli GL
Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1761-7. PubMed ID: 10397696
[TBL] [Abstract][Full Text] [Related]
36. The relation between erythrocyte volume and folate levels is influenced by a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T).
Lalouschek W; Aull S; Serles W; Wolfsberger M; Deecke L; Pabinger-Fasching I; Mannhalter C
J Investig Med; 2000 Jan; 48(1):14-20. PubMed ID: 10695265
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients.
Ducloux D; Ruedin C; Gibey R; Vautrin P; Bresson-Vautrin C; Rebibou JM; Chalopin JM
Nephrol Dial Transplant; 1998 Nov; 13(11):2890-3. PubMed ID: 9829496
[TBL] [Abstract][Full Text] [Related]
38. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke.
Glueck CJ; Fontaine RN; Wang P
Thromb Haemost; 2001 Feb; 85(2):256-9. PubMed ID: 11246543
[TBL] [Abstract][Full Text] [Related]
39. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis.
Cantu C; Alonso E; Jara A; Martínez L; Ríos C; Fernández Mde L; Garcia I; Barinagarrementeria F
Stroke; 2004 Aug; 35(8):1790-4. PubMed ID: 15192249
[TBL] [Abstract][Full Text] [Related]
40. The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants.
Ono H; Sakamoto A; Mizoguchi N; Sakura N
Brain Dev; 2002 Jun; 24(4):223-6. PubMed ID: 12015164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
